Hisamitsu Pharmaceutical : Notification Regarding Application for Selection of “Prime Market” Under the New Market Segments
October 14, 2021 at 02:12 am EDT
Share
This material is an English translation of the press release announced on Oct. 14, 2021 in Japanese, and the Japanese release is given priority about the content and the interpretation.
Oct. 14, 2021
Notification Regarding Application for Selection of "Prime Market"
Under the New Market Segments
Hisamitsu Pharmaceutical Co., Inc. (Head Office: Tosu City, Saga Prefecture; President and CEO: Kazuhide Nakatomi; hereinafter referred to as "Hisamitsu") hereby notices that Hisamitsu has resolved at the Board of Directors Meeting held on October 14, 2021, to select the "Prime Market" as Hisamitsu's new market segment on the Tokyo Stock Exchange ("TSE") and to file an application for this selection.
Hisamitsu received the results of the initial assessment of the Hisamitsu's compliance with the listing standards of the new market segments from TSE on July 9, 2021, and confirmed that Hisamitsu is in compliance with the listing standards for the "Prime Market" under the new market segments.
Hisamitsu will proceed with the application procedure for the selection of the new market segment in accordance with the schedule set forth by the TSE.
Attachments
Original document
Permalink
Disclaimer
Hisamitsu Pharmaceutical Co. Ltd. published this content on 14 October 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 14 October 2021 06:11:05 UTC.
Hisamitsu Pharmaceutical Co Inc is a Japan-based company mainly engaged in the pharmaceutical business. The Company is engaged in the manufacture, sale and supply of pharmaceuticals and related products, and the operation of over-the-counter drug (OTC) business. It is also engaged in the manufacture and sale of drugs in the United States, Brazil, Vietnam, and Indonesia, the development work in Europe, the drug marketing and sales in China and Hong Kong. It is also engaged in the urban cable television broadcasting business, Internet connection service business, non-life insurance agency business, advertising agency business and the purchase, manufacture and sale of packing materials.
HISAMITSU PHARMACEUTICAL CO., INC. 
